Glucagen Hypokit

Glucagen Hypokit contains the active ingredient glucagon and is supplied as a ready‑to‑use kit for intramuscular, intravenous, or subcutaneous administration. It is a prescription product marketed in the European Union and is used to rapidly raise blood glucose levels in patients experiencing severe hypoglycemia.

Glucagen Hypokit is indicated for the emergency treatment of severe hypoglycemia when oral glucose is not feasible. It is used by healthcare professionals and trained caregivers in acute settings.

- Adults and children with insulin‑induced hypoglycemia - Patients with diabetes who cannot self‑treat low blood sugar - Situations where rapid glucose elevation is required - Administration by emergency medical services - Use in hospitals, clinics, or home settings under supervision

Glucagen Hypokit may cause a range of side effects, most of which are mild and transient. Serious adverse events are less common but require immediate medical attention.

Common: - Nausea or vomiting - Flushing or warmth sensation - Headache - Dizziness - Injection site pain or irritation - Transient rise in blood pressure

Serious: - Allergic reactions such as rash, itching, or swelling - Severe hypotension or hypertension - Cardiac arrhythmias - Persistent hyperglycemia requiring medical management

Before using Glucagen Hypokit, consider the following precautions to ensure safe and effective treatment.

- Verify the diagnosis of severe hypoglycemia before administration - Use only as directed by a qualified healthcare professional - Monitor blood glucose levels after injection to assess response - Avoid repeated dosing without medical supervision - Store the kit according to manufacturer instructions, protecting it from extreme temperatures - Keep the product out of reach of children and dispose of used syringes safely

Glucagen Hypokit can interact with other medications, influencing its effectiveness or safety profile.

Avoid: - Beta‑blockers, which may mask typical glucagon side effects - Certain calcium channel blockers that could affect cardiovascular response

Use with caution: - Insulin and other hypoglycemic agents, as they may require dose adjustments - Anticholinergic drugs that could alter gastrointestinal motility - Medications that affect hepatic glycogen stores, such as corticosteroids